# Wellth

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/wellth

- Industry: Healthcare IT
- Headquarters: Los Angeles, US
- Website: www.wellthapp.com
- Total disclosed funding: $101M
- Latest round: Series B (Aug 21, 2025)
- Investors on record: 23

## About

Founded in 2014 and headquartered in Los Angeles, US, Wellth, Inc. is focused on improving health management for chronic condition patients. The company has successfully raised USD 25.00 mn in its Series B funding round led by SignalFire, with participation from Maycomb Capital, Healthworx, and FJ Labs. So far, Wellth has completed 7 deals, with the most recent funding round occurring on August 21, 2025. The founders, Alec Zopf, Beth Bedingfield, and Matthew Loper, have backgrounds in health technology and entrepreneurship, with Matthew Loper currently serving as CEO.

Wellth’s primary offering is a daily care motivation platform designed to improve medication adherence and overall health outcomes for individuals managing chronic conditions. The platform incentivizes users to engage with their healthcare routines through behavioral economics principles, providing personalized support tailored to patients' needs. Key functionalities include medication adherence tracking, clinical value monitoring (such as A1c and blood pressure), and reminders for attending provider appointments and getting necessary screenings. Wellth serves a diverse client base that includes Medicare Advantage plans, Medicaid programs, employers, and individuals within the ACA Marketplace, focusing on improving health behaviors and increasing Star Ratings across various measures. The platform is available in multiple geographical markets, catering to users across the United States, aiming to enhance health engagement and adherence in a variety of demographic groups.

Wellth generates revenue primarily through partnerships with health plans, employers, and healthcare providers who implement its platform to improve member health outcomes. The transaction structure typically involves B2B arrangements, where health plans pay for access to Wellth’s services to support their members' care management efforts. Revenue is driven by subscription-based models or performance-based agreements, where health plans may pay based on the achievement of specific health outcomes or adherence metrics. Wellth’s flagship service includes a comprehensive app that offers daily check-ins and rewards for healthy behaviors, facilitating continuous engagement with users. The pricing structure reflects the value delivered through increased adherence rates and reduced healthcare costs, directly benefiting Wellth’s clients and their patient populations.

In August 2025, Wellth, Inc. raised USD 25.00 mn in Series B funding to support the further development of its platform. The company plans to expand its offerings with new products focused on enhancing user engagement and health outcomes, though specific release dates are not yet disclosed. Additionally, Wellth aims to expand into new markets, targeting regions across the United States to increase its footprint and accessibility. The recent funding will be instrumental in facilitating these growth initiatives.

## Funding rounds

- Series B, Aug 21, 2025, $25M — FJ Labs, SignalFire, Maycomb Capital, Healthworx
- Series C, Aug 20, 2025, $36M — Comcast Ventures, Mercato, CD-Venture, SignalFire, NYL Ventures, FCA Venture Partners
- Series B, Feb 8, 2023, $23M — Partnership Fund for New York City, CD-Venture, Yabeo Capital, SignalFire, Beyond Capital, Maycomb Capital
- Series A, May 6, 2020, $10M — Boehringer Ingelheim Venture, I2BF, Rock Health, CD-Venture, Partnership Fund for New York City, AXA Venture Partners, Yabeo Capital, NYL Ventures, NFP Ventures, DaVita Venture Group
- Seed, Sep 7, 2018, $5.1M — Boehringer Ingelheim Venture, Partnership Fund for New York City, NFP Corp., CD-Venture, AXA Venture Partners, Yabeo Capital, NYL Ventures
- Seed, May 25, 2016, $2M — I2BF, Altair Capital, AXA Venture Partners, Koh Founders, Beta Bridge Capital, B-Fore Capital

## Investors

- I2BF (https://capitalatlas.ai/funds/i2bf) — Seed, Series A
- Altair Capital — Seed
- AXA Venture Partners (https://capitalatlas.ai/funds/axa-venture-partners) — Seed, Series A
- Koh Founders — Seed
- Beta Bridge Capital (https://capitalatlas.ai/funds/beta-bridge-capital) — Seed
- B-Fore Capital — Seed
- Boehringer Ingelheim Venture (https://capitalatlas.ai/funds/boehringer-ingelheim-venture) — Seed, Series A
- Partnership Fund for New York City (https://capitalatlas.ai/funds/partnership-fund-for-new-york-city) — Seed, Series A, Series B
- NFP Corp. — Seed
- CD-Venture (https://capitalatlas.ai/funds/cd-venture) — Seed, Series A, Series B, Series C
- Yabeo Capital (https://capitalatlas.ai/funds/yabeo-capital) — Seed, Series A, Series B
- NYL Ventures (https://capitalatlas.ai/funds/nyl-ventures) — Seed, Series A, Series C
- Rock Health (https://capitalatlas.ai/funds/rock-health) — Series A
- NFP Ventures (https://capitalatlas.ai/funds/nfp-ventures) — Series A
- DaVita Venture Group (https://capitalatlas.ai/funds/davita-venture-group) — Series A
- SignalFire (https://capitalatlas.ai/funds/signalfire) — Series B, Series C
- Beyond Capital — Series B
- Maycomb Capital — Series B
- Comcast Ventures (https://capitalatlas.ai/funds/comcast-ventures) — Series C
- Mercato (https://capitalatlas.ai/funds/mercato) — Series C
- FCA Venture Partners (https://capitalatlas.ai/funds/fca-venture-partners) — Series C
- FJ Labs (https://capitalatlas.ai/funds/fj-labs) — Series B
- Healthworx (https://capitalatlas.ai/funds/healthworx) — Series B